DeepPsy AG

Help psychiatrists find the best treatment.

We help psychiatrists identify the best treatment for patients with depression, including medications and other biomedical interventions. Before treatment begins, we analyze brain data from EEG and ECG and generate a medical report to support clinical decision making. Our focus is on treatment decisions that are currently driven by trial and error, improving outcomes by +24% while reducing treatment costs.

The solution is regulatory approved in Switzerland and recently in the UK and UAE. It is fully reimbursed and actively used in Switzerland. With EU approval expected in Q3 2026, and DeepPsy is ready to scale.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

24.06.2026

The Swiss National Medtech Team 2026 is set for Boston (startupticker.ch)

17.04.2025

DeepPsy: Biomarker-Analyse über Grundversicherung abgedeckt (startupticker.ch)

27.08.2024

Future of Health Grant steps up with 8 new startups (startupticker.ch)

23.05.2022

>>venture>> announces 15 winners (startupticker.ch)

Last Tweets

Tweets by TwitterDev

31.12.2025

1'000 DeepPsy Reports Delivered

01.04.2025

Approval to charge basic insurance.

20.05.2024

Launch of Medical Service on the Swiss market

25.09.2023

We achieved ISO13485 certification for medical devices.

No Jobs

No videos and documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (150'000) 2021

Website